SPECT brain imaging in patients with suspected Parkinsonian syndromes.
Hauser, RA, and DG Grosset. 2012. “SPECT Brain Imaging in Patients With Suspected Parkinsonian Syndromes.”. J Neuroimaging.
Search
Search results
1935 results found
Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations.
Hersh, BP, NL Earl, RA Hauser, and M Stacy. 2010. “Early Treatment Benefits of Ropinirole Prolonged Release in Parkinson’s Disease Patients With Motor Fluctuations.”. Mov Disord.
Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.
Colosimo, C, P Martinez-Martin, G Fabbrini, RA Hauser, M Merello, J Miyasaki, W Poewe, et al. 2010. “Task Force Report on Scales to Assess Dyskinesia in Parkinson’s Disease: Critique and Recommendations.”. Mov Disord.
Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease.
Rascol, O, P Barone, RA Hauser, Y Mizuno, W Poewe, AH Schapira, L Salin, M Sohr, and C Debieuvre. 2010. “Efficacy, Safety, and Tolerability of Overnight Switching from Immediate- to Once Daily Extended-Release Pramipexole in Early Parkinson’s Disease.”. Mov Disord.
The independent influence of apathy and depression on cognitive functioning in Parkinson's disease
Butterfield, LC, CR Cimino, LE Oelke, RA Hauser, and J Sanchez-Ramos. 2010. “The Independent Influence of Apathy and Depression on Cognitive Functioning in Parkinson’s Disease”. Neuropsychology.
TEMPO Open-label Study Group. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.
Hauser, RA, MF Lew, HI Hurtig, WG Ondo, J Wojcieszek, and CJ Fitzer-Attas. 2009. “TEMPO Open-Label Study Group. Long-Term Outcome of Early versus Delayed Rasagiline Treatment in Early Parkinson’s Disease.”. Mov Disord.
ADAGIO Study Investigators. A double-blind, delayed-start trial of rasagiline in Parkinson's disease.
Olanow, CW, O Rascol, RA Hauser, PD Feigin, J Jankovic, A Lang, W Langston, et al. 2009. “ADAGIO Study Investigators. A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson’s Disease.”. N Engl J Med.
Placebo response in Parkinson’s disease: Comparisons among 11 trials covering medical and surgical interventions
Goetz, CG, J Wuu, MP McDermott, CH Adler, S Fahn, CR Freed, RA Hauser, et al. 2008. “Placebo Response in Parkinson’s Disease: Comparisons Among 11 Trials Covering Medical and Surgical Interventions”. Mov Disord.
A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results
Investigators, The NINDS NET-PD, and RA Hauser. 2008. “A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease: 18-Month Results”. Clin Neuropharmacol.
A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics.
Olanow, CW, RA Hauser, J Jankovic, W Langston, A Lang, W Poewe, E Tolosa, et al. 2008. “A Randomized, Double-Blind, Placebo-Controlled, Delayed Start Study to Assess Rasagiline As a Disease Modifying Therapy in Parkinson’s Disease (the ADAGIO Study): Rationale, Design, and Baseline Characteristics.”. Mov Disord.